Form 4 for AGEN AGENUS INC
Accepted 2025-07-15 00:00:00 ET · period of report 2025-06-17 · accession 0000950170-25-095865 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-15 | 2025-07-01 | AGEN | HARRISON THOMAS L | Dir | A - Grant | $3.46 | +7,401 | 16.3K | +83% | +$25.6K |
| D | 2025-07-15 | 2025-06-17 | AGEN | HARRISON THOMAS L | Dir | A - Grant | $0.00 | +17.5K | 30.0K | +140% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-01 | A | A | 7,401 | $3.46 | 16,299 | D | — | — | (F1) Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive their director fees in shares of Ageuns' common stock. (F2) $3.462 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued. |
| 2 | Derivative | Stock Option | 2025-06-17 | A | A | 17,500 | $0.00 | 30,000 | D | $3.02 · — to 2035-05-28 | 17,500 Common Stock | (F3) Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date. |